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Abstract This experiment was performed to evaluate the effect
of thyroid-stimulating hormone (TSH) on the endoplasmic
reticulum resident 29 kDa protein (ERp29) gene expression in
the thyrocytes of FRTL-5 cells. Although ERp29 mRNA was
constantly expressed, its expression began to increase remark-
ably from 1039 M TSH. On the other hand, the effect of TSH
on the abundance of ERp29 mRNA started within 6 h and
peaked at 8 h. Actinomycin D strongly blocked this effect
while cycloheximide did not. The half-life of ERp29 mRNA was
about 4^4.5 h in the presence or absence of TSH that was not
affected by the stability of ERp29 mRNA. The effect of TSH on
the ERp29 gene expression was specific, while other growth
factors (transferrin, insulin and hydrocortisone) did not alter
its expression. Our data indicate for the first time that the
expression of ERp29 is regulated transcriptionally by TSH
in thyrocytes. ß 2000 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
One of the most important jobs of the endoplasmic retic-
ulum (ER) is to provide an environment that facilitates the
proper folding and assembly of newly synthesized secretory
proteins and plasma membrane proteins. This organelle con-
tains numerous ER chaperones, ER foldases and ER degra-
dases that assist in ER quality control, including the degra-
dation of mis/unfolded proteins that permit the exit of
completely folded proteins only [1]. Recently, it has been re-
ported that a new ER resident 29 kDa protein (ERp29) from
the enamel cells is one of the highly conserved members of the
ER chaperones (such as grp94, calreticulin, PDI and BiP).
The ERp29 gene was found to be ubiquitously expressed
and was activated in response to ER stress. The cDNA of
ERp29 encodes a putative 260 amino acids with 28 574 Da
and pI 5.6. The ERp29 protein was abundant (approximately
0.2% of soluble protein) and had an ER-retrieval signal, the
C-terminal tetrapeptide KEEL. In the cells, the ERp29 pro-
tein interacts with an ER chaperone of BiP/grp78 and is as-
sembled in a homodimer with a thioredoxin-like structure [2^
4].
Most ER resident stress proteins are induced transcription-
ally in response to the starvation of glucose, glycosylation
inhibition, perturbation of ER stores of Ca2, blocking the
transport of proteins from the ER to the Golgi body and
induction of reducing agents and heavy metals [5^9].
Although some information for the ERp29 gene itself and
the proteins widely expressed in animal tissues and stress-in-
ducible in the ER were reported [2^4], the exact biological
function of ERp29 and its gene expression by hormone are
still unclear. With this in mind, we tested the hormonal ex-
pression of ERp29 in the cells whose expression was thyroid-
stimulating hormone (TSH)-dependently increased, and chose
the thyroid culture cells (FRTL-5 cells) that have been well
studied with respect to ER chaperones [10,11].
As a step toward elucidating the function of the ERp29 in
thyrocytes, it was necessary to know how the ERp29 gene is
controlled by TSH in FRTL-5 cells. Actually, it is well known
that TSH dominantly regulates the thyroid hormone synthesis
in the thyrocytes [12]. We recently isolated the cDNA frag-
ment that encodes partial ERp29 from the FRTL-5 cells using
a di¡erential display-PCR method, which was TSH-depen-
dently regulated under the transcription level [13]. At present,
however, the e¡ect of TSH on the ERp29 gene expression is
still quite unclear. With this in mind, we investigated the
mRNA expression of ERp29 in the cellular response against
TSH by Northern blot analysis. The data in this study cover
the ¢rst set of results, showing that TSH speci¢cally controls
ERp29 gene expression in the thyrocytes.
2. Materials and methods
2.1. Materials
Highly puri¢ed bovine TSH was obtained either from the hormone
distribution program of the National Institute of Diabetes and Diges-
tive and Kidney Diseases, National Institute of Health (NIDDK-
bTSH I-1: 30 U/mg) or was a previously described preparation,
26 þ 3 U/mg, homogeneous in the ultracentrifuge, about 27 500 in
molecular weight, with the amino acid and carbohydrate composition
of TSH. [32P]dATP (3000 Ci/mmol) was from DuPont-New England
Nuclear (Boston, MA, USA) [14]. The source of all other materials
used in this study was Sigma (St. Louis, MO, USA) unless otherwise
noted.
2.2. Cell culture
The rat thyroid cell line FRTL-5 (American Type Culture Collec-
tion, CRL #8305, Rockville, MD, USA) was cultured in Coon’s me-
dium, containing 5% calf serum and 1039 M TSH, 5 Wg/ml transferrin,
1 Wg/ml insulin and 10 nM hydrocortisone, at 37‡C in a humid at-
mosphere with 5% CO2 [10]. Their doubling time with TSH was 36 þ
6 h; they did not proliferate without TSH. The cells were diploid
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between their 5th and 20th passage. A fresh medium was added to the
cells every 2 or 3 days and the cells were passaged every 2 weeks. As
an individual experiment, the cells were washed three times with cold
phosphate-bu¡ered saline (PBS) to completely remove the hormones
and then were incubated for 48 h in growth medium without hor-
mones.
2.3. RNA isolation and Northern analysis
After various TSH concentrations, incubation times and treatment
of other agents, the con£uent FRTL-5 cells were scraped from the
Petri dishes with a rubber policeman into 10 ml of cold PBS and
collected by clinical centrifugation for 3 min at 2000Ug. The pellet
was disrupted by Dounce homogenization with a tight-¢tting pestle in
15 ml of lysis bu¡er (10 mM Tris, pH 7.5, 10 mM KCl, 1.5 mM
MgCl2, 0.25% Triton X-100). The suspension containing total RNA
was layered on top of a 1.2 ml cushion of 5.7 M CsCl in 0.1 M EDTA
and centrifuged at 15‡C for 24 h at 36 000 rpm in a Beckman SW55
rotor. The RNA pellet was treated with 500 Wg/ml of proteinase K in
an extraction bu¡er (1% SDS, 0.01 mM Tris, pH 7.5, 5 WM EDTA).
After phenol and ether extractions, the RNA pellet was suspended in
DEPC-treated water and the yield was determined twice for each
sample using an UV spectrophotometer.
The mRNA expression level of the ERp29 was analyzed by North-
ern blotting. Equal amounts of RNA (20 Wg) were separated on a
denaturing agarose gel (2.5% agarose containing 2.2 M formaldehyde)
and transferred to a nylon membrane (Boehringer, Germany). After
the ¢lter was UV-crosslinked (UV-Stratalinker 1800, Stratagene), it
was prehybridized in a high SDS bu¡er (7% SDS, 50% formamide,
5USSC, 2% blocking reagent, 50 mM sodium phosphate) at 50‡C for
2 h. Hybridization was performed with the same SDS bu¡er contain-
ing [32P]dATP leveled ERp29 DNA fragments at 50‡C overnight. The
nylon membrane was rinsed twice with 2USSC and 0.1% SDS at
room temperature. The membrane was then exposed to an X-ray
¢lm in a deep-freeze for a period of time between 5 h and 1 day to
allow the mRNA signals to develop. The ERp29 DNA fragments
were isolated from the agarose gel by a silica-based matrix of DNA
PreMate1 Kit (Bioneer, Korea) and were radio-labeled by the ran-
dom primer method using a kit (Amersham Life Science, Arlington
Heights, IL, USA) and used as molecular probes for Northern blot
analysis. For quanti¢cation, a phosphorimaging analyzer was used to
measure the hybridization signals (Molecular Dynamics).
3. Results and discussion
3.1. TSH dose/time-dependent ERp29 mRNA expression
We ¢rst determined whether the ERp29 gene was activated
in the thyrocytes of the FRTL-5 cells stimulated by TSH. The
cells were incubated in a control growth medium with 5% calf
serum and without TSH, transferrin, insulin or hydrocorti-
sone (called 4H) for 2 days to completely remove the hormo-
nal e¡ect. Various concentrations of TSH were added to the
growth media for 24 h. As shown in Fig. 1A,B, the ERp29
mRNA was constantly expressed in the absence of TSH (con-
trol) and its expression began to increase gradually relative to
the added TSH concentration.
When 1039 M TSH was added, a remarkable expression
was detected in the FRTL-5 cells. No data for the gene ex-
pression mechanism of ERp29 by TSH have ever been shown,
so this ¢nding is the ¢rst to show that TSH increased the
mRNA level of ERp29 in the thyrocytes. Considering the
fact that ERp29 belongs to the ER stress protein, similar
expression patterns are not a strong argument because, in
general, the heat shock protein expression increased rapidly
only early on and for a short time after external stimulations
(e.g. heat, heavy metal, metabolically toxic matters or un-
folded protein accumulation) [5^9]. Based on the results
shown in Fig. 1, we suggest that ERp29 mRNA expression
is required for the physiological role under normal cell con-
ditions and TSH enhances its expression.
Next, we examined the e¡ect of TSH on the ERp29 mRNA
expression over time during a 24 h exposure. The FRTL-5
cells were incubated for the indicated number of hours in
the presence of 1039 M TSH after preincubation for 2 days
in a growth medium with 5% calf serum and without 4H (Fig.
1C,D). Although the signal of the ERp29 expression was de-
tected when the cells were not chased, its expression was in-
Fig. 1. TSH in£uences ERp29 mRNA expression: dose- and time-dependent induction. Con£uent FRTL-5 cells were treated with the indicated
doses of TSH at 37‡C for 24 h, after treatment for 2 days with 5% calf serum and without 4H in the growth medium. Total RNA was isolated
as described in Section 2 and was subjected to Northern blotting. A: TSH enhancement of the ERp29 mRNA. An arrow indicates ERp29
(upper panel), and an ethidium bromide staining of the 18S ribosomal RNA (lower panel) was used to indicate the equivalence of the load on
the gel. B: Quanti¢cation of ERp29 mRNA bands in (A). C: The e¡ects of Erp29 on TSH mRNA over time. Each cell treated with 1039 M
TSH for 24 h in the 4H medium. An arrow indicates ERp29 (upper panel) and an ethidium bromide staining of the 18S ribosomal RNA (low-
er panel) was used to indicate the equivalence of the load on the gel. D: The quanti¢cation of (C) by phosphorimaging. Both (B) and (D)
were performed with duplicate samples and the results were averages of repeated experiments. Statistical comparison of paired mean values (i.e.
TSH treatment versus control).
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creased gradually by chase periods for 24 h. There was a time-
dependent increase in the ERp29 mRNA expression, which
peaked at 8 h (approximately ¢ve-fold) in three independent
experiments compared to its measure at 0 h, and then de-
creased thereafter.
Recent studies have revealed the early expression of genes
in the thyrocytes in response to growth, proliferation and
di¡erentiation stimuli, but they did not describe the stress-in-
ducible genes. The mRNA levels of the tested genes (c-myc,
jun B and fos B) were strongly increased, but the mRNA
levels of c-jun and egr were decreased by TSH. Those remark-
able expression signals were detectable within 2^4 h after
the TSH-treatment [15]. The ERp29 gene shows immediate
early expression due to stress, but at the present we do not
fully understand its expression mechanism. It is not so strange
that the ERp29 gene expression (by TSH) takes longer (ap-
proximately 6^8 h as shown in Fig. 1C,D) compared to stress-
es.
3.2. E¡ects of transcription and protein synthesis inhibitors
for the ERp29 expression
To investigate the mode of TSH action in the regulation of
the ERp29 gene expression, the FRTL-5 cells were treated for
24 h with actinomycin D (AD; inhibitor for transcription) [16]
and cycloheximide (CH; inhibitor for protein synthesis) [17] in
the presence or absence of 1039 M TSH after preincubation
for 2 days in the growth media with 5% calf serum and with-
out 4H. The result of Northern blotting is shown in Fig. 2. As
already shown in Fig. 1, TSH alone fully increased the ERp29
mRNA expression in the FRTL-5 cells. When the cells were
treated with 0.2 Wg/ml AD in the presence or absence of TSH,
the resulting signal of ERp29 mRNA was completely abol-
ished whether TSH was present or not.
On the other hand, for the cells treated with 2 Wg/ml CH in
the presence or absence of TSH, the expression pattern of
ERp29 was similar to that of the control, although its expres-
sion was weak. This weakness is due to the activation of
preexisting ERp29 mRNAs, which already become aggravated
before the AD treatment. This result suggests that the ERp29
mRNA expression is completely regulated at the transcrip-
tional level but there is no translational/posttranscriptional
regulation in the thyrocytes. Although TSH alone fully enhan-
ces the ERp29 expression, TSH promotes only one expression
pathway for the transcriptional up/down regulation of the
ERp29, as shown in Fig. 2. The cells treated with TSH were
combined with AD, where the unenhanced signal was shown.
If TSH had taken one of the alternative pathways for the
ERp29 expression, some strong signal should have been
shown when the cells were treated with TSH+AD.
3.3. Estimation of ERp29 mRNA half-life
We demonstrated the e¡ects of TSH on ERp29 mRNA
stability using 25 Wg/ml DRB (5,6-dichloro-1-L-D-ribofurano-
sylbenzimidazole), which is a speci¢c inhibitor of RNA poly-
merase II [18]. The DRB treatment prevents new mRNA syn-
thesis and permits the monitoring of intracellular residue
mRNAs. As shown in Fig. 3A,B, no signals in either the
presence or absence of TSH were commonly detected after
8 h of treatment of DRB on the FRTL-5 cells. This means
that the already aggravated ERp29 mRNA was almost de-
cayed, as the amount of ERp29 mRNA became aggravated
just before the treatment of DRB. The half-life of ERp29
Fig. 2. E¡ects of AD and CH on TSH-induced accumulation of
ERp29 mRNA. Con£uent FRTL-5 cells were treated either with (+)
or without (3) 1039 M TSH for 24 h in the presence or absence of
0.2 Wg/ml AD or 2 Wg/ml CH after 48 h without any hormones as
the growth medium. Total RNA was isolated as described in Sec-
tion 2 and was subjected to Northern blotting. An arrow indicates
ERp29 (upper panel) and an ethidium bromide staining of the 18S
ribosomal RNA (lower panel) was used to indicate the equivalence
of the load on the gel.
Fig. 3. E¡ect of TSH on the stability of ERp29 mRNA in FRTL-5
cells. A: Con£uent FRTL-5 cells were treated with DRB (25 Wg/ml)
at 37‡C and chased for 17 h in the presence (+) or absence (3) of
1039 M TSH. Total RNA was isolated and subjected to Northern
blotting as described in Section 2. An arrow indicates ERp29 (upper
panels) and ethidium bromide staining of the 18S ribosomal RNA
(lower panels) was used to indicate the equivalence of the load on
the gel. B: Quanti¢cation of ERp29 mRNA bands in (A). The ex-
periments above were performed with duplicate samples and the re-
sults were averages of repeated experiments. Statistical comparison
of paired mean values (i.e. DRB treatment versus control). Presence
(circles) or absence (rhombs) of 1039 M TSH.
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mRNA in the FRTL-5 cells was about 4 h in the absence of
TSH and approximately 4.5 h in the presence of TSH.
Graphing the data from the DRB experiment, there was no
serious di¡erence between the control and TSH-treated
groups. This means that the stability of the ERp29 mRNA
was not largely a¡ected in either the presence or absence of
TSH in the FRTL-5 cells. That is to say, TSH is not involved
in the step after transcription, which is e¡ective only in the
gene expression step. In addition, both signals seemed to be
enhanced after 17 h of the DRB treatment because of the
inactivation of the DRB that was already added by a single
term of incubation (at 37‡C) and because the signal when
TSH was present appeared stronger than when TSH was ab-
sent.
3.4. TSH speci¢c expression of ERp29
In general, the transcription of a gene requires several fac-
tors that make a large transcriptional complex [19]. Therefore,
we examined the e¡ects of these growth factors (e.g. trans-
ferrin, insulin, hydrocortisone; essential for growth of FRTL-
5 culture cells) on ERp29 gene regulation in the presence or
absence of TSH. The cells were treated for 24 h with 5 Wg/ml
transferrin, 1 Wg/ml insulin and 10 nM hydrocortisone, in the
presence or absence of 1039 M TSH after preincubation for
two days in the growth media with 5% calf serum and without
4H.
As shown in Fig. 4, the transferrin, insulin and hydrocorti-
sone did not remarkably a¡ect the constant ERp29 mRNA
levels in the FRTL-5 cells in either the presence or absence of
TSH. When TSH was added together with growth factors, the
ERp29 expression was not additive and TSH alone increased
the ERp29 mRNA levels. This shows that TSH speci¢cally
a¡ects the ERp29 expression, at least in FRTL-5 cells, while
the growth factors of transferrin, insulin and hydrocortisone
play an important role in the growth of FRTL-5 cells. If the
growth factors a¡ect the ERp29 expression, some strong sig-
nals should have been shown when the cells were treated with
a combination of TSH, transferrin, insulin and hydrocorti-
sone. However, as shown in Fig. 4, no strong signals were
found when the cells were treated with additional growth
factors, compared to the signal produced by the treatment
of TSH on its own.
In conclusion, our data demonstrate that TSH strictly con-
trols the ERp29 gene expression at the transcriptional level in
the thyrocytes. Considering that the ERp29 mRNA was con-
stantly expressed in the cells that were not treated with TSH,
in conjunction with the data from previous reports, it may be
concluded that the ERp29 molecule is involved in the cell
homeostatics (e.g. the ER-retrieval signal, stress inducibility,
protein maturation in the ER and stress defense in the ER), as
well as the association with other ER chaperones. Also, the
TSH-speci¢c expression of ERp29 suggests that it might have
a unique role. We are now interested in the functional role of
ERp29 as an ER chaperone in the thyrocytes, in that it might
help the folding and assembly of the thyroid prohormone
thyroglobulin.
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Fig. 4. Speci¢city of the TSH e¡ect on the enhancement of ERp29
mRNA. Con£uent FRTL-5 cells were treated for 24 h either with
(+) or without (3) 1039 M TSH in the presence of transferrin (5
Wg/ml), insulin (1 Wg/ml) and 10 nM hydrocortisone after 48 h with-
out any hormones as the growth medium. Total RNA was isolated
as described in and was subjected to Northern blotting. An arrow
indicates ERp29 (upper panel), and an ethidium bromide staining of
the 18S ribosomal RNA (lower panel) was used to indicate the
equivalence of the load on the gel. Abbreviations: i (insulin),
t (transferrin), h (hydrocortisone).
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